Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Feras M. Hantash"'
Autor:
Kimberly S. Cole, Zhiqiang Li, Amy Tiersten, Wanying Zhang, Hussam Al-Kateb, Feras M. Hantash, Michael R. Rossi, Scott Newman, Xiang Zhou, Eric E. Schadt, Rong Chen, William K. Oh, Marc Y. Fink
Publikováno v:
Cancer Research. 82:P3-09
As sequencing technologies advance, there is increasing interest in the value of more comprehensive molecular profiling techniques. Our laboratory has clinically validated two next generation sequencing (NGS) assays for detecting somatic variants in
Autor:
Philip C Mack, Michael I Klein, Kristin L Ayers, Xiang Zhou, Sunny Guin, Marc Fink, Michael Rossi, Hussam AI-Kateb, Timmy O’Connell, Feras M Hantash, William K Oh, Scott Newman, Eric E Schadt, Rong Chen, Fred R Hirsch
Publikováno v:
The oncologist. 27(6)
Introduction Historically, high rates of actionable driver mutations have been reported in never-smokers with lung adenocarcinoma (ADC). In the era of modern, comprehensive cancer mutation sequencing, this relationship necessitates a more detailed an
Autor:
Ron S. Newfield, Wen Jiang, Daniel X. Sugganth, Feras M. Hantash, Euyhyun Lee, Robert O. Newbury
Publikováno v:
International Journal of Pediatric Otorhinolaryngology. 157:111121
We previously described mutation rates of BRAFSingle-center retrospective cohort examining thyroidectomy tissue blocks from consecutive pediatric WDTC patients between 2001 and 2015. Tissues were analyzed at Quest Diagnostics for BRAF, RAS mutations,
Autor:
José Baselga, Feras M. Hantash, Tiffany A. Traina, Antonio M. P. Omuro, James J. Harding, Julia E. Rudolph, Margaret K. Callahan, Daniel C. Danila, Rona Yaeger, Alan L. Ho, Ederlinda Paraiso, Hongxin Zhang, Michael F. Berger, Ritika Kundra, Ahmet Zehir, Leonard B. Saltz, Ping Chi, Douglas A. Levine, Gregory J. Riely, Neerav Shukla, David M. Hyman, Moriah H. Nissan, Alexandra Snyder, Mrinal Gounder, Yelena Y. Janjigian, Maeve A. Lowery, Matthew D. Hellmann, Debyani Chakravarty, Tara Soumerai, Sarah Fierberg Phillips, Marc Ladanyi, Shrujal S. Baxi, Andrew Grupe, Thomas Kaley, Barry S. Taylor, Jiaojiao Wang, Martin H. Voss, Paul Sabbatini, David B. Solit, Dana Rathkopf, Alexander N. Shoushtari, Nikolaus Schultz, Gopa Iyer, Jianjiong Gao, Paul K. Paik, Michael A. Postow, Sarat Chandarlapaty, Matthew T. Chang
Publikováno v:
JCO Precision Oncology. :1-16
Purpose With prospective clinical sequencing of tumors emerging as a mainstay in cancer care, an urgent need exists for a clinical support tool that distills the clinical implications associated with specific mutation events into a standardized and e
Autor:
Fahim Abbasi, Feras M. Hantash, David Feldman, Michael P. Caulfield, Christine Blasey, Gerald M. Reaven
Publikováno v:
The Journal of Nutrition. 145:714-719
Background: Individuals with prediabetes mellitus (PreDM) and low circulating 25-hydroxyvitamin D [25(OH)D] are at increased risk of type 2 diabetes mellitus (T2DM). Objective: We aimed to determine whether low 25(OH)D concentrations are associated w
Publikováno v:
American Journal of Hypertension. 28:266-272
There is substantial epidemiological evidence that low plasma concentrations of 25-hydroxyvitamin D (25(OH)D) are associated with increased risk of developing hypertension,1,2 although not all studies agree.3 Furthermore, analysis of data from the 20
Autor:
Matthew James Butler, Feras M. Hantash, Alexander F. Lovejoy, Li Liu, Keith M. Gligorich, Maria E. Arcila, Bharathi Anekella, Christian Gloeckner, Yves Konigshofer, Ravindra Kohle, Chen Zhao, Russell Garlick, Omoshile Clement, Carrie Sougnez, Ahmet Zehir, Niall J. Lennon, Anthony Martin Magliocco
Publikováno v:
Journal of Clinical Oncology. 37:e14746-e14746
e14746 Background: Next Generation Sequencing based assays are designed to detect genomic aberrations in a limited number of target regions. However, there is a need for accurate measurement of tumor mutational burden (TMB) as low as 4 to as high as
Autor:
David Ross, Cindy Barlan, John J. Sninsky, James Prentice, Heather R. Sanders, Feras M. Hantash, Kevin Qu, Xi Zhang, Beryl Crossley, Anthony Sferruzza, Hai-Rong Li, Joseph J. Catanese, Andrew Grupe, Lin Ma, David Wolfson, Frederic Waldman
Publikováno v:
Molecular diagnosistherapy. 20(3)
Several targeted therapies have been approved for treatment of solid tumors. Identification of gene mutations that indicate response to these therapies is rapidly progressing. A 34-gene next-generation sequencing (NGS) panel, developed and validated
Autor:
Michael J. McPhaul, Feras M. Hantash, Robert O. Newbury, Wen Jiang, Ron S. Newfield, Frederic Waldman, Shih-Min Cheng, Maria Nikita, Richard E. Reitz, Susan A. Phillips
Publikováno v:
Thyroid : official journal of the American Thyroid Association, vol 26, iss 2
Thyroid
Thyroid
BackgroundWell-differentiated thyroid cancer (WDTC) incidence in pediatrics is rising, most being papillary thyroid carcinoma (PTC). The objective of the study was to assess the prevalence of different mutations in pediatric WDTC and correlate the ge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3994fb8816c87dff7a38b7253a433d6
https://escholarship.org/uc/item/43t6g95t
https://escholarship.org/uc/item/43t6g95t
Autor:
Beryl Crossley, Feras M. Hantash, Charles M. Strom, Dana M. Goos, Ben Anderson, Ke Zhang, Weimin Sun
Publikováno v:
Genetics in Medicine. 13:39-45
Fragile X syndrome is caused by expansion and methylation of a CGG tract in the 5' untranslated region of the FMR1 gene. The estimated frequency of expanded alleles (≥55 repeats) in the United States is 1:257-1:382, but these estimates were not cal